Brightstar Associates LLC 3
3 · Deciphera Pharmaceuticals, Inc. · Filed Sep 28, 2017
Insider Transaction Report
Form 3
Brightstar Associates LLC
10% Owner
Holdings
Series B-1 Preferred Stock
→ Common Stock (2,237,445 underlying)Series B Preferred Stock
→ Common Stock (1,678,219 underlying)Series C Preferred Stock
→ Common Stock (1,491,549 underlying)Series A Preferred Stock
→ Common Stock (11,165,157 underlying)
Footnotes (1)
- [F1]Represents preferred stock of Deciphera Pharmaceuticals, LLC. Upon the closing of the Issuer's initial public offering, each share of preferred stock will automatically be converted into 5.65 shares of common stock of the Issuer.